Global Stem Cells Market Research and Analysis, 2014-2020
MARKET INSIGHTS
Global stem cell market is expected to grow at a CAGR of 23% for the forecasted period of 2015-2020. The market is segmented on the basis of products, technology and application. Stem cell are undifferentiated cells which have the capability of multiplying in ‘n’ number of cells. Stem cells are of two types- adult stem cells and embryonic stem cells. Stem cells are being studied for their unique regenerative properties. They are being used in drug discovery programs to develop new drugs and treatment methods. Stem cell research is also being used to study genetic disorders, birth defects and other growth factors. Stem cell banks are being established which store stem cells and umbilical cord blood containing stem cells. These are used for treating the individual in future. Stem cell banking is gaining popularity amongst modern day parents who opt to store their new-born’s cells to prevent any future ailments. Stem cell are being used to treat and diagnose cancer. Stem cell are great part of understanding and treating cancer; especially in children.
Stem cell is being funded by governments, NGO’s and private firms considering the great potential it has in changing the shape of healthcare. New gene editing technologies such as CRISPR are also going to boost the stem cell research and market could witness influx of a number of products.
Regionally, North America and Europe make up for 70% of the total market. North American and European companies are well funded and well equipped. More number of start-ups are emerging. These companies are also attracting a lot of investment. Asia Pacific market is expected to grow at a healthy growth rate for the forecasted period of 2015-2020. A significant amount of research is going on in countries such as India, China, Japan and Israel.
Global stem cell market is expected to grow at a CAGR of 23% for the forecasted period of 2015-2020. The market is segmented on the basis of products, technology and application. Stem cell are undifferentiated cells which have the capability of multiplying in ‘n’ number of cells. Stem cells are of two types- adult stem cells and embryonic stem cells. Stem cells are being studied for their unique regenerative properties. They are being used in drug discovery programs to develop new drugs and treatment methods. Stem cell research is also being used to study genetic disorders, birth defects and other growth factors. Stem cell banks are being established which store stem cells and umbilical cord blood containing stem cells. These are used for treating the individual in future. Stem cell banking is gaining popularity amongst modern day parents who opt to store their new-born’s cells to prevent any future ailments. Stem cell are being used to treat and diagnose cancer. Stem cell are great part of understanding and treating cancer; especially in children.
Stem cell is being funded by governments, NGO’s and private firms considering the great potential it has in changing the shape of healthcare. New gene editing technologies such as CRISPR are also going to boost the stem cell research and market could witness influx of a number of products.
Regionally, North America and Europe make up for 70% of the total market. North American and European companies are well funded and well equipped. More number of start-ups are emerging. These companies are also attracting a lot of investment. Asia Pacific market is expected to grow at a healthy growth rate for the forecasted period of 2015-2020. A significant amount of research is going on in countries such as India, China, Japan and Israel.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUG AND DEVICE REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
2.7. PATENT ANALYSIS
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
3.1.2. POPULARITY RISING TO DUE TO INCREASED RESEARCH ESPECIALLY IN THE FIELD OF ONCOLOGY
3.1.3. GROWING NUMBER OF STEM CELL BANKS
3.1.4. GROWING RESEARCH IN PAEDIATRICS
3.1.5. GROWING USAGE OF THERAPEUTIC APPLICATION OVER NO THERAPEUTIC APPLICATIONS
3.2. RESTRAINT
3.2.1. LONG APPROVAL PROCESSES AND TOUGH CLINICAL TRIAL REGULATIONS
3.2.2. HIGH COST OF THERAPEUTIC APPLICATIONS
3.2.3. HIGH COST OF STEM CELL RESEARCH AND LIMITED FINANCIAL SUPPORT FROM GOVERNMENTS
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL STEM CELLS BY PRODUCTS MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1. GLOBAL ADULT STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.1. GLOBAL HEMATOPOIETIC STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.2. GLOBAL MESENCHYMAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.3. GLOBAL NEURONAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.4. GLOBAL DENTAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.5. GLOBAL UMBILICAL CORD STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.2. GLOBAL HUMAN EMBRYONIC STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.3. GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.4. GLOBAL RAT NEURAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.5. GLOBAL OTHER STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.2. GLOBAL STEM CELLSBY TECHNOLOGY MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.1. GLOBAL STEM CELL ACQUISITION MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.1.1. GLOBAL THERAPEUTIC CLONING FOR STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.1.2. GLOBAL IVF STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.1.3. GLOBAL STEM CELL CULTURE MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.2. GLOBAL STEM CELL CRYOPRESERVATION MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.3. GLOBAL STEM CELLS EXPANSION AND SUB-CULTURE MARKET RESEARCH AND ANALYSIS 2014-2020
5.3. GLOBAL STEM CELLS BY APPLICATION MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.1. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2. GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.1. GLOBAL NEUROLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.2. GLOBAL ORTHOPEDICS MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.3. GLOBAL ONCOLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.4. GLOBAL HEMATOLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.5. GLOBAL CVD MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.6. GLOBAL INJURIES MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.7. GLOBAL DIABETES MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.8. GLOBAL LIVER DISORDERS MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.9. GLOBAL OTHER STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2014-2020
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
8.1. ALLOSOURCE
8.1.1. INTRODUCTION
8.1.2. PRODUCT PORTFOLIO
8.1.3. RECENT ACTIVITIES
8.1.4. SWOT
8.2.ANTEROGEN
8.2.1. INTRODUCTION
8.2.2. PRODUCT PORTFOLIO
8.2.3. RECENT ACTIVITIES
8.2.4. SWOT
8.3. APCETH
8.3.1. INTRODUCTION
8.3.2. PRODUCT PORTFOLIO
8.3.3. RECENT ACTIVITIES
8.3.4. SWOT
8.4. BIOHEART
8.4.1. INTRODUCTION
8.4.2. PRODUCT PORTFOLIO
8.4.3. RECENT ACTIVITIES
8.4.4. SWOT
8.5. CELL CURE NEUROSCIENCES
8.5.1. INTRODUCTION
8.5.2. PRODUCT PORTFOLIO
8.5.3. RECENT ACTIVITIES
8.5.4. SWOT
8.6. GAMIDA CELL
8.6.1. INTRODUCTION
8.6.2. PRODUCT PORTFOLIO
8.6.3. RECENT ACTIVITIES
8.6.4. SWOT
8.7. MEDIPOST
8.7.1. INTRODUCTION
8.7.2. PRODUCT PORTFOLIO
8.7.3. RECENT ACTIVITIES
8.7.4. SWOT
8.8. MESOBLAST
8.8.1. INTRODUCTION
8.8.2. PRODUCT PORTFOLIO
8.8.3. RECENT ACTIVITIES
8.8.4. SWOT
8.9. NEOSTEM
8.9.1. INTRODUCTION
8.9.2. PRODUCT PORTFOLIO
8.9.3. RECENT ACTIVITIES
8.9.4. SWOT
8.10. NEURALSTEM
8.10.1. INTRODUCTION
8.10.2. PRODUCT PORTFOLIO
8.10.3. RECENT ACTIVITIES
8.10.4. SWOT
8.11. NUVASIVE
8.11.1. INTRODUCTION
8.11.2. PRODUCT PORTFOLIO
8.11.3. RECENT ACTIVITIES
8.11.4. SWOT
8.12. OCATA THERAPEUTICS
8.12.1. INTRODUCTION
8.12.2. PRODUCT PORTFOLIO
8.12.3. RECENT ACTIVITIES
8.12.4. SWOT
8.13. ORTHOFIX
8.13.1. INTRODUCTION
8.13.2. PRODUCT PORTFOLIO
8.13.3. RECENT ACTIVITIES
8.13.4. SWOT
8.14. OSIRIS THERAPEUTICS
8.14.1. INTRODUCTION
8.14.2. PRODUCT PORTFOLIO
8.14.3. RECENT ACTIVITIES
8.14.4. SWOT
8.15. PHARMICELL
8.15.1. INTRODUCTION
8.15.2. PRODUCT PORTFOLIO
8.15.3. RECENT ACTIVITIES
8.15.4. SWOT
8.16. PLURISTEM THERAPEUTICS
8.16.1. INTRODUCTION
8.16.2. PRODUCT PORTFOLIO
8.16.3. RECENT ACTIVITIES
8.16.4. SWOT
8.17. RELIANCE LIFE SCIENCES
8.17.1. INTRODUCTION
8.17.2. PRODUCT PORTFOLIO
8.17.3. RECENT ACTIVITIES
8.17.4. SWOT
8.18. RENEURON
8.18.1. INTRODUCTION
8.18.2. PRODUCT PORTFOLIO
8.18.3. RECENT ACTIVITIES
8.18.4. SWOT
8.19. RTI SURGICAL
8.19.1. INTRODUCTION
8.19.2. PRODUCT PORTFOLIO
8.19.3. RECENT ACTIVITIES
8.19.4. SWOT
8.20. STEMPEUTICS
8.20.1. INTRODUCTION
8.20.2. PRODUCT PORTFOLIO
8.20.3. RECENT ACTIVITIES
8.20.4. SWOT
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUG AND DEVICE REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
2.7. PATENT ANALYSIS
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
3.1.2. POPULARITY RISING TO DUE TO INCREASED RESEARCH ESPECIALLY IN THE FIELD OF ONCOLOGY
3.1.3. GROWING NUMBER OF STEM CELL BANKS
3.1.4. GROWING RESEARCH IN PAEDIATRICS
3.1.5. GROWING USAGE OF THERAPEUTIC APPLICATION OVER NO THERAPEUTIC APPLICATIONS
3.2. RESTRAINT
3.2.1. LONG APPROVAL PROCESSES AND TOUGH CLINICAL TRIAL REGULATIONS
3.2.2. HIGH COST OF THERAPEUTIC APPLICATIONS
3.2.3. HIGH COST OF STEM CELL RESEARCH AND LIMITED FINANCIAL SUPPORT FROM GOVERNMENTS
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL STEM CELLS BY PRODUCTS MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1. GLOBAL ADULT STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.1. GLOBAL HEMATOPOIETIC STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.2. GLOBAL MESENCHYMAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.3. GLOBAL NEURONAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.4. GLOBAL DENTAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.1.5. GLOBAL UMBILICAL CORD STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.2. GLOBAL HUMAN EMBRYONIC STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.3. GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.4. GLOBAL RAT NEURAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.1.5. GLOBAL OTHER STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.2. GLOBAL STEM CELLSBY TECHNOLOGY MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.1. GLOBAL STEM CELL ACQUISITION MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.1.1. GLOBAL THERAPEUTIC CLONING FOR STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.1.2. GLOBAL IVF STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.1.3. GLOBAL STEM CELL CULTURE MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.2. GLOBAL STEM CELL CRYOPRESERVATION MARKET RESEARCH AND ANALYSIS 2014-2020
5.2.3. GLOBAL STEM CELLS EXPANSION AND SUB-CULTURE MARKET RESEARCH AND ANALYSIS 2014-2020
5.3. GLOBAL STEM CELLS BY APPLICATION MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.1. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2. GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.1. GLOBAL NEUROLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.2. GLOBAL ORTHOPEDICS MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.3. GLOBAL ONCOLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.4. GLOBAL HEMATOLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.5. GLOBAL CVD MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.6. GLOBAL INJURIES MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.7. GLOBAL DIABETES MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.8. GLOBAL LIVER DISORDERS MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
5.3.2.9. GLOBAL OTHER STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2014-2020
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
8.1. ALLOSOURCE
8.1.1. INTRODUCTION
8.1.2. PRODUCT PORTFOLIO
8.1.3. RECENT ACTIVITIES
8.1.4. SWOT
8.2.ANTEROGEN
8.2.1. INTRODUCTION
8.2.2. PRODUCT PORTFOLIO
8.2.3. RECENT ACTIVITIES
8.2.4. SWOT
8.3. APCETH
8.3.1. INTRODUCTION
8.3.2. PRODUCT PORTFOLIO
8.3.3. RECENT ACTIVITIES
8.3.4. SWOT
8.4. BIOHEART
8.4.1. INTRODUCTION
8.4.2. PRODUCT PORTFOLIO
8.4.3. RECENT ACTIVITIES
8.4.4. SWOT
8.5. CELL CURE NEUROSCIENCES
8.5.1. INTRODUCTION
8.5.2. PRODUCT PORTFOLIO
8.5.3. RECENT ACTIVITIES
8.5.4. SWOT
8.6. GAMIDA CELL
8.6.1. INTRODUCTION
8.6.2. PRODUCT PORTFOLIO
8.6.3. RECENT ACTIVITIES
8.6.4. SWOT
8.7. MEDIPOST
8.7.1. INTRODUCTION
8.7.2. PRODUCT PORTFOLIO
8.7.3. RECENT ACTIVITIES
8.7.4. SWOT
8.8. MESOBLAST
8.8.1. INTRODUCTION
8.8.2. PRODUCT PORTFOLIO
8.8.3. RECENT ACTIVITIES
8.8.4. SWOT
8.9. NEOSTEM
8.9.1. INTRODUCTION
8.9.2. PRODUCT PORTFOLIO
8.9.3. RECENT ACTIVITIES
8.9.4. SWOT
8.10. NEURALSTEM
8.10.1. INTRODUCTION
8.10.2. PRODUCT PORTFOLIO
8.10.3. RECENT ACTIVITIES
8.10.4. SWOT
8.11. NUVASIVE
8.11.1. INTRODUCTION
8.11.2. PRODUCT PORTFOLIO
8.11.3. RECENT ACTIVITIES
8.11.4. SWOT
8.12. OCATA THERAPEUTICS
8.12.1. INTRODUCTION
8.12.2. PRODUCT PORTFOLIO
8.12.3. RECENT ACTIVITIES
8.12.4. SWOT
8.13. ORTHOFIX
8.13.1. INTRODUCTION
8.13.2. PRODUCT PORTFOLIO
8.13.3. RECENT ACTIVITIES
8.13.4. SWOT
8.14. OSIRIS THERAPEUTICS
8.14.1. INTRODUCTION
8.14.2. PRODUCT PORTFOLIO
8.14.3. RECENT ACTIVITIES
8.14.4. SWOT
8.15. PHARMICELL
8.15.1. INTRODUCTION
8.15.2. PRODUCT PORTFOLIO
8.15.3. RECENT ACTIVITIES
8.15.4. SWOT
8.16. PLURISTEM THERAPEUTICS
8.16.1. INTRODUCTION
8.16.2. PRODUCT PORTFOLIO
8.16.3. RECENT ACTIVITIES
8.16.4. SWOT
8.17. RELIANCE LIFE SCIENCES
8.17.1. INTRODUCTION
8.17.2. PRODUCT PORTFOLIO
8.17.3. RECENT ACTIVITIES
8.17.4. SWOT
8.18. RENEURON
8.18.1. INTRODUCTION
8.18.2. PRODUCT PORTFOLIO
8.18.3. RECENT ACTIVITIES
8.18.4. SWOT
8.19. RTI SURGICAL
8.19.1. INTRODUCTION
8.19.2. PRODUCT PORTFOLIO
8.19.3. RECENT ACTIVITIES
8.19.4. SWOT
8.20. STEMPEUTICS
8.20.1. INTRODUCTION
8.20.2. PRODUCT PORTFOLIO
8.20.3. RECENT ACTIVITIES
8.20.4. SWOT
LIST OF TABLES
TABLE # 1 GLOBAL STEM CELLS BY PRODUCTS MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 2 GLOBAL ADULT STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 3 GLOBAL HEMATOPOIETIC STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 4 GLOBAL MESENCHYMAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 5 GLOBAL NEURONAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 6 GLOBAL DENTAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 7 GLOBAL UMBILICAL CORD STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 8 GLOBAL HUMAN EMBRYONIC STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 9 GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 10 GLOBAL RAT NEURAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 11 GLOBAL OTHER STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 12 GLOBAL STEM CELLS BY TECHNOLOGY MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 13 GLOBAL STEM CELL ACQUISITION MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 14 GLOBAL THERAPEUTIC CLONING FOR STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 15 GLOBAL IVF STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 16 GLOBAL STEM CELL CULTURE MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 17 GLOBAL STEM CELL CRYOPRESERVATION MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 18 GLOBAL STEM CELLS EXPANSION AND SUB-CULTURE MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 19 GLOBAL STEM CELLS BY APPLICATION MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 20 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 21 GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 22 GLOBAL NEUROLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 23 GLOBAL ORTHOPEDICS MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 24 GLOBAL ONCOLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 25 GLOBAL HEMATOLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 26 GLOBAL CVD MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 27 GLOBAL INJURIES MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 28 GLOBAL WOUND CARE MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 29 GLOBAL SPINAL CORD INJURY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 30 GLOBAL OTHER INJURY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 31 GLOBAL DIABETES MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 32 GLOBAL LIVER DISORDERS MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 33 GLOBAL OTHER STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 1 GLOBAL STEM CELLS BY PRODUCTS MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 2 GLOBAL ADULT STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 3 GLOBAL HEMATOPOIETIC STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 4 GLOBAL MESENCHYMAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 5 GLOBAL NEURONAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 6 GLOBAL DENTAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 7 GLOBAL UMBILICAL CORD STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 8 GLOBAL HUMAN EMBRYONIC STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 9 GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 10 GLOBAL RAT NEURAL STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 11 GLOBAL OTHER STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 12 GLOBAL STEM CELLS BY TECHNOLOGY MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 13 GLOBAL STEM CELL ACQUISITION MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 14 GLOBAL THERAPEUTIC CLONING FOR STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 15 GLOBAL IVF STEM CELL MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 16 GLOBAL STEM CELL CULTURE MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 17 GLOBAL STEM CELL CRYOPRESERVATION MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 18 GLOBAL STEM CELLS EXPANSION AND SUB-CULTURE MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 19 GLOBAL STEM CELLS BY APPLICATION MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 20 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 21 GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 22 GLOBAL NEUROLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 23 GLOBAL ORTHOPEDICS MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 24 GLOBAL ONCOLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 25 GLOBAL HEMATOLOGY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 26 GLOBAL CVD MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 27 GLOBAL INJURIES MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 28 GLOBAL WOUND CARE MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 29 GLOBAL SPINAL CORD INJURY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 30 GLOBAL OTHER INJURY MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 31 GLOBAL DIABETES MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 32 GLOBAL LIVER DISORDERS MEDICINES MARKET RESEARCH AND ANALYSIS 2014-2020
TABLE # 33 GLOBAL OTHER STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2014-2020
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. ALLOSOURCE
2..ANTEROGEN
3. APCETH
4. BIOHEART
5. CELL CURE NEUROSCIENCES
6. GAMIDA CELL
7. MEDIPOST
8. MESOBLAST
9. NEOSTEM
10. NEURALSTEM
11. NUVASIVE
12. OCATA THERAPEUTICS
13. ORTHOFIX
14. OSIRIS THERAPEUTICS
15. PHARMICELL
16. PLURISTEM THERAPEUTICS
17. RELIANCE LIFE SCIENCES
18. RENEURON
19. RTI SURGICAL
20. STEMPEUTICS
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. ALLOSOURCE
2..ANTEROGEN
3. APCETH
4. BIOHEART
5. CELL CURE NEUROSCIENCES
6. GAMIDA CELL
7. MEDIPOST
8. MESOBLAST
9. NEOSTEM
10. NEURALSTEM
11. NUVASIVE
12. OCATA THERAPEUTICS
13. ORTHOFIX
14. OSIRIS THERAPEUTICS
15. PHARMICELL
16. PLURISTEM THERAPEUTICS
17. RELIANCE LIFE SCIENCES
18. RENEURON
19. RTI SURGICAL
20. STEMPEUTICS
